IDEXX Laboratories, Inc. vs KKR & Co Inc — how do they compare? IDEXX Laboratories, Inc. trades at $546.1 (market cap $43.58B), while KKR & Co Inc trades at $94.71 (market cap $87.19B). The key difference: KKR & Co Inc is far larger — about 2× IDEXX Laboratories, Inc.'s market cap, and KKR & Co Inc pays a 0.77% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | KKR | |
|---|---|---|
Market Cap | $43.58B | $87.19B |
Sector | Health | Financials |
52-Week High | $766.68 | $152.16 |
52-Week Low | $526.44 | $83.88 |
Enterprise Value | $44.48B | $12.72B |
Dividend Yield | — | 0.77% |
Trailing returns across standard periods
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →KKR is one of the world's largest alternative asset managers, with $490.7 billion in total assets under management, including $384.5 billion in fee-earning AUM, at the end of June 2022. The company has two core segments: asset management (which includes private markets--private equity, credit, infrastructure, energy and real estate--and public markets--primarily credit and hedge/investment fund platforms) and insurance (following the February 2021 purchase of a 61.5% economic stake in Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance). On the asset management side, private markets account for 50% of fee-earning AUM and 70% of base management fees, while public markets account for 50% and 30%, respectively.
Read more on KKR →